Alithea Genomics raised €1.0M in a funding round in May 2022. The company is based in Lausanne, Switzerland. Investors in the round: Novalis Biotech Acceleration fund. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €1.0M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
